A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Post-CAR-T Cell Therapy (Consolidation and Relapse): Acute Lymphoblastic Leukaemia
[chapter]
2022
The EBMT/EHA CAR-T Cell Handbook
Preserved Fulltext
AbstractRole of consolidative allogeneic haematopoietic cell transplantation (allo-HCT) for B-cell acute lymphoblastic leukaemia (B-ALL) patients in minimal residual disease-negative (MRD) complete remission (CR) after CD19 CAR-T cell therapy.
doi:10.1007/978-3-030-94353-0_32
fatcat:fxnkl6uc25c7vh4ynj5n4pspae